世界のトリアムシノロン軟膏クロロフルオロカーボン市場 2020年-2025年

• 英文タイトル:Triamcinolone Ointment Chlorofluorocarbons Market - Growth, Trends, and Forecast (2020 - 2025)

Triamcinolone Ointment Chlorofluorocarbons Market - Growth, Trends, and Forecast (2020 - 2025)「世界のトリアムシノロン軟膏クロロフルオロカーボン市場 2020年-2025年」(市場規模、市場予測)調査レポートです。• レポートコード:D0-MOR-AP1164
• 出版社/出版日:Mordor Intelligence / 2020年4月
• レポート形態:英文、PDF、115ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:健康管理
• 販売価格(消費税別)
  Single User¥459,000 (USD4,250)▷ お問い合わせ
  Team User¥513,000 (USD4,750)▷ お問い合わせ
  Corporate License¥810,000 (USD7,500)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは、トリアムシノロン軟膏クロロフルオロカーボンの世界市場について調査・分析した資料で、トリアムシノロン軟膏クロロフルオロカーボンの市場概要、動向、セグメント別市場規模、地域別分析、競争状況、企業情報、市場機会分析などで構成されています。

Skin disease is one of the leading causes of the increasing global disease burden, affecting millions of people worldwide. Triamcinolone is basically used to treat the inflammation caused by many conditions that include allergic reactions, eczema, and psoriasis. Aging, environmental and genetic factors result in the development of a diverse number of skin diseases. As people age, their risk of developing skin-related disorders increases, due to factors, such as changes in the connective tissue, reduction in the skin’s strength and elasticity, and reduction in secretions from sebaceous glands. Hence, the rising cases of skin disease and increasing levels of awareness are expected to drive the market. However, factors such as adverse side effects associated with the product may have a negative impact on market growth.
Key Market Trends

Allergies Segment is Expected to Show Better Growth in the Forecast Years

Based on Application, the market is segmented into Eczema, Dermatitis, Allergies, Psoriasis, and Others. Allergy tends to be more common in children as compared to adults. Triamcinolone works by controlling inflammation and calming overactive immune systems. It may be taken for a short term or a long-term basis, depending on the severity of the condition as it reduces the swelling, itching, and redness that occurs due to allergy. According to the BSACI (British Society for Allergy and Clinical Immunology), in the United Kingdom, the prevalence of diseases such as allergic rhinitis (one in five), asthma (one in three), and eczema (one in six), are quite high, which is expected to fuel the increasing demand for triamcinolone ointment over the forecast period.

North America holds the Largest Share in the Triamcinolone Ointment Chlorofluorocarbons Market

The triamcinolone ointment chlorofluorocarbons market holds the largest share in the North America region due to increasing healthcare expenditure, awareness about skin diseases, and the strong presence of major companies. An increasing number of skin cancer cases are also found in the United States. According to the American Cancer Society, in 2020, around 6,850 people are expected to die of melanoma in the United States. Hence, with the increasing incidence of dermatological diseases and well-developed infrastructure, the market is expected to grow in the forecast period.

Competitive Landscape

Many new players are emerging in this market, as a result of a number of growth opportunities. The global players into the triamcinolone ointment chlorofluorocarbons market are Akorn Inc., Bristol Myers Squibb Company, Cosette Pharmaceuticals, Inc., Glenmark Pharmaceuticals, Lupin Limited, Mylan N.V., Novartis International AG, Sun Pharmaceutical Industries Limited and Taro Pharmaceutical Industries.

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format
– 3 months of analyst support

レポート目次

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Cases of Skin Disorders
4.2.2 Growing Geriatric Population
4.2.3 Rising Awareness among the Population
4.3 Market Restraints
4.3.1 Adverse Side Effects Associated with the Product
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Application
5.1.1 Eczema
5.1.2 Dermatitis
5.1.3 Allergies
5.1.4 Psoriasis
5.1.5 Others
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle-East & Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle-East and Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Akorn Inc.
6.1.2 Bristol Myers Squibb Company
6.1.3 Cosette Pharmaceuticals, Inc.
6.1.4 Glenmark Pharmaceuticals
6.1.5 Lupin Limited
6.1.6 Mylan N.V.
6.1.7 Novartis International AG
6.1.8 Sun Pharmaceutical Industries Limited
6.1.9 Taro Pharmaceutical Industries

7 MARKET OPPORTUNITIES AND FUTURE TRENDS




• 英文レポート名:Triamcinolone Ointment Chlorofluorocarbons Market - Growth, Trends, and Forecast (2020 - 2025)
• 日本語訳:世界のトリアムシノロン軟膏クロロフルオロカーボン市場 2020年-2025年
• レポートコード:D0-MOR-AP1164お問い合わせ(見積依頼・ご注文・質問)